BW

06
Jun
By MetroLatinoUSA
BW

Transgene Presented Additional Phase I Data with TG4050 (myvac® platform) at ASCO 2022

STRASBOURG, France--(BUSINESS WIRE)--Regulatory News: Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced that it presented updated preliminary Phase I data on TG4050, its individualized neoantigen cancer vaccine, in a poster session at the American Society of Clinical…
Leer más...
06
Jun
By MetroLatinoUSA
BW

Skyhigh Security Advances Safe Hybrid Work Environments With Portfolio Enhancements at RSA Conference 2022

Skyhigh Security SSE portfolio addresses multiple use cases, protecting data regardless of where it lies SAN JOSE, Calif.--(BUSINESS WIRE)--RSA CONFERENCE--Skyhigh Security today announced new enhancements to its Secure Service Edge (SSE) platform at RSA Conference 2022. These latest innovations to Skyhigh Security’s Secure Web Gateway (SWG), Cloud Access Security Broker…
Leer más...
06
Jun
By MetroLatinoUSA
BW

Perimeter 81 Secures $100 Million Series C Funding Led By B Capital, Leading to $1 Billion Valuation

Funding will further accelerate the development and distribution of SSE offering NEW YORK--(BUSINESS WIRE)--#NetworkSecurity--Perimeter 81, the leading Security Service Edge (SSE) and Zero Trust Network Access (ZTNA) provider, is valued at $1 billion after completing this week a $100 million Series C funding round led by B Capital. Participating investors…
Leer más...
05
Jun
By MetroLatinoUSA
BW

TURNING POINT THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Turning Point Therapeutics, Inc. – TPTX

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Turning Point Therapeutics, Inc. (NasdaqGS: TPTX) to Bristol Myers Squibb (NYSE: BMY). Under the terms of the proposed transaction, shareholders of…
Leer más...
05
Jun
By MetroLatinoUSA
BW

Latest Data of InnoCare’s Orelabrutinib for the Treatment of SLE Presented at LBA Session of EULAR 2022

BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969), a leading biotech company, announced today that Professor Zhanguo Li, the leading PI, has presented latest data of BTK inhibitor orelabrutinib for the treatment of Systemic Lupus Erythematosus (SLE) at the just-concluded EULAR 2022 European Congress of Rheumatology. The abstract was selected as late-breaking oral…
Leer más...
05
Jun
By MetroLatinoUSA
BW

Bigfoot Unity® Demonstrates Strong Glycemic Control Among People with Type 2 Diabetes in Real-World Retrospective Analysis

Data Were Presented at the American Diabetes Association 82nd Scientific Sessions MILPITAS, Calif.--(BUSINESS WIRE)--Bigfoot Biomedical, a mission-driven company dedicated to supporting better health outcomes for people with insulin-requiring diabetes, presented real-world data from its late-breaking abstract presented at the American Diabetes Association 82nd Annual Scientific Sessions. Data from the real-world…
Leer más...
¡Síguenos en Facebook!
¡Síguenos en Twitter!